Market News

Reviewing Progenics Pharmaceuticals Inc. (PGNX)’s and Cambrex Corporation (NYSE:CBM)’s results

Both Progenics Pharmaceuticals Inc. (NASDAQ:PGNX) and Cambrex Corporation (NYSE:CBM) are Biotechnology companies, competing one another. We will compare their institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Progenics Pharmaceuticals Inc. 5 -0.02 68.58M -0.85 […]

Reviewing Twelve Seas Investment Company (BROGU)’s and Bioceres Crop Solutions Corp. (NYSEAMERICAN:BIOX)’s results

As Conglomerates companies, Twelve Seas Investment Company (NASDAQ:BROGU) and Bioceres Crop Solutions Corp. (NYSEAMERICAN:BIOX) are our subject to compare. And more specifically their analyst recommendations, profitability, risk, institutional ownership, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Twelve Seas Investment […]

Contrasting of QAD Inc. (QADB) and SolarWinds Corporation (NYSE:SWI)

QAD Inc. (NASDAQ:QADB) and SolarWinds Corporation (NYSE:SWI), are influenced by contrast since they are both players in the Application Software. These factors are particularly influence the institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation of the two firms. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]

Reviewing ServiceSource International Inc. (SREV)’s and Tenable Holdings Inc. (NASDAQ:TENB)’s results

This is therefore a comparing of the analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation in ServiceSource International Inc. (NASDAQ:SREV) and Tenable Holdings Inc. (NASDAQ:TENB). The two are both Business Software & Services companies that compete with one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income […]

Comparison of Chiasma Inc. (CHMA) and 22nd Century Group Inc. (NYSEAMERICAN:XXII)

This is a contrast between Chiasma Inc. (NASDAQ:CHMA) and 22nd Century Group Inc. (NYSEAMERICAN:XXII) based on their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Pluristem Therapeutics Inc. (PSTI)’s Financial Results Comparing With VistaGen Therapeutics Inc. (NASDAQ:VTGN)

Pluristem Therapeutics Inc. (NASDAQ:PSTI) and VistaGen Therapeutics Inc. (NASDAQ:VTGN) are two firms in the Biotechnology that compete against each other. Below is a comparison of their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Seneca Biopharma Inc. (SNCA) and Brickell Biotech Inc. (NASDAQ:BBI) Comparing side by side

As Biotechnology companies, Seneca Biopharma Inc. (NASDAQ:SNCA) and Brickell Biotech Inc. (NASDAQ:BBI) are our subject to contrast. And more specifically their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Seneca Biopharma Inc. 1 0.00 […]

Genmab A/S (GMAB) and Vir Biotechnology Inc. (NASDAQ:VIR) Contrasting side by side

Genmab A/S (NASDAQ:GMAB) and Vir Biotechnology Inc. (NASDAQ:VIR) compete against each other in the Biotechnology sector. We will contrast them and contrast their profitability, analyst recommendations, institutional ownership, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genmab A/S 22 […]